产品名称
MISSION® esiRNA, targeting mouse Anxa5
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
AACCTGTTGACATCCCGAAGCAATGCTCAGCGCCAGGAAATTGCTCAGGAGTTTAAGACTCTGTTTGGCAGGGACCTTGTGGATGACCTGAAGTCTGAACTGACTGGAAAGTTTGAGAAGTTAATTGTGGCTATGATGAAGCCCTCACGACTCTACGATGCCTACGAGCTGAAGCATGCTCTTAAGGGAGCTGGTACAGACGAGAAAGTATTGACCGAGATTATTGCTTCAAGGACACCTGAAGAACTCAGTGCCATAAAACAAGTTTATGAAGAAGAATATGGTTCCAACCTGGAAGATGATGTGGTGGGGGATACTTCAGGGTACTACCAGAGGATGTTGGTGGTCCTCCTTCAGGCGAATAGAGACCCTGATACTGCAATTGATGATGCTCAAGTTGAACTGGATGCTCAGGCATTGTTCCAGGCTGGAGAGCTGAAGTGGGGGACAGATGAAGAAAAATTCATCACCATCTTTGGGACA
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
mouse ... ANXA5(11747), Anxa5(11747)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Nahee Park et al.
Journal of toxicology and environmental health. Part A, 77(22-24), 1467-1476 (2014-10-25)
Auranofin is a lipophilic gold compound with anti-inflammatory and immunosuppressive properties. This compound also exerts antiproliferative effects in several human cancer cell lines. Although auranofin induces apoptosis in human cancer cells, the underlying mechanisms remain unclear. This study investigated auranofin-mediated
Jingjing Wang et al.
Oncology reports, 32(6), 2557-2563 (2014-10-18)
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma worldwide. Although patient outcomes have significantly improved to a greater than 40% cure rate by the combinatorial cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy, which is widely
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持